Title : Gefitinib (ZD1839) combined with weekly epirubicin in patients with metastatic breast cancer: a phase I study with biological correlate.

Pub. Date : 2005 Dec

PMID : 16107496






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EGFR suppression by gefitinib, a quinazoline derivative that inhibits phosphorylation of the specific receptor, represents a novel therapeutic strategy. Quinazolines epidermal growth factor receptor Homo sapiens